FRONT PAGE: Pharma image hit by Seroxat scare
Eighty-six per cent of the public think the reputation of the pharma industry has been damaged by GlaxoSmithKline's delay in coming clean about its Seroxat drug, a PRWeek poll has found.
Philip Thomson
More like this
- REPUTATION CHECK: Will Seroxat scandal damage GSK?
- Healthcare: GSK ends corporate comms head search
- News Analysis: GSK trials register raises PR stakes
- LEADER: Pharma sector must face its demons
- At a glance: Anti-depressant prescriptions to children
- Healthcare: GSK handles Paxil crisis in-house
- GSK handles Paxil crisis in-house
- Brand Watch reveals extent of GP concern over Seroxat
- GSK allegations heighten industry's reputational woes
- At a glance: The UK Social Investment Forum (UKSIF)
Tags
Jobs
- Account Director :: EXPERIENTIAL :: COOL BRANDS
- £40K-£45K + benefits
- Senior Account Manager or Account Director
- £30k - £45k + bens + bonus
- Director of Marketing
- £47,250 - £53,500
- Account Manager
